Results per Page:
When on-target misses the mark: Lessons from HIV immunogens
From the McGuire Lab, Vaccine and Infectious Disease Division
Fred Hutch Cancer Center announces 2025 Evergreen Fund awardees
Nine Fred Hutch researchers receive funding totaling $1.175 million for projects with commercial partnership potential
Repping Epstein-Barr virus: RNA vaccine protects against cancer in mice
From the McGuire lab, Vaccine and Infectious Disease Division
Inching closer to an EBV vaccine?
From the McGuire lab, Vaccine and Infectious Diseases Division
Antibodies from infected patients are a template for a SARS-CoV-2 vaccine
From the McGuire, Pancera, and Stamatatos labs, Vaccine and Infectious Disease Division
Antibody blocks Epstein-Barr virus in preclinical trial
Hutch-discovered protein blocks virus linked to cancers, mono, autoimmune diseases
Clues from coronavirus’ past
From the University of Washington and the McGuire lab, Vaccine and Infectious Disease Division